Dr. Michael Gregory Hurtuk, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2850 W 95th St, Suite 306, Evergreen Park, IL 60805 Phone: 708-422-8500 |
Monica L Lorimer, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2850 W. 95th St, Suite 306, Evergreen Park, IL 60805 Phone: 708-422-8500 Fax: 708-499-7872 |
Farhad Vossoughi, MD Surgery Medicare: Medicare Enrolled Practice Location: 2800 W 95th St, Evergreen Park, IL 60805 Phone: 630-321-2710 |
Dr. Abdul Haye Khan, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2850 W 95th St, Suite 102, Evergreen Park, IL 60805 Phone: 708-636-4116 Fax: 708-636-5346 |
Dr. David Shapiro, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 9125 S Pulaski Rd, Evergreen Park, IL 60805 Phone: 708-422-7715 Fax: 708-422-7816 |
Michael R Fiorucci, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2850 W 95th St, Suite 306, Evergreen Park, IL 60805 Phone: 708-422-8500 Fax: 708-229-6081 |
News Archive
Volcano Corporation today announced it has received clearance to market the PrimeWire PRESTIGE pressure guide wire in Japan. In addition to accurately measuring intravascular pressure via Fractional Flow Reserve, the PrimeWire PRESTIGE pressure guide wire delivers superior handling with a frontline tip design, enhanced torque and more support.
Unravelling the mechanical properties of bone with micro-indentation testing has significance in both health and disease. At the University Medical Center Hamburg-Eppendorf, Dr. Björn Busse and his research group have advanced their micro-indentation testing technique using an Olympus industrial inspection digital light microscope, as an alternative to electron microscopy. The cutting edge research is described in a new application note from Olympus, available online.
Yesterday, the American College of Rheumatology met with U.S. Department of Health and Human Services Secretary Alex Azar for a productive discussion about the rheumatology community's concerns with a new policy that will allow Medicare Advantage plans to utilize step therapy in Medicare Part B.
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.
Cancer cells can develop resistance to therapy through both genetic and non-genetic mechanisms. But it is unclear how and why one of these routes to resistance prevails.
› Verified 4 days ago